Girard Partners’s Patterson-UTI PTEN Stock Holding History

Girard Partners’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-500	Closed	-$8K	–	670
2018 Q3	$8K	Buy	+500	New	+$8.59K	﹤0.01%	780

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Girard Partners's PTEN Position: Q4 2018 in Review

Girard Partners sold out of Patterson-UTI (PTEN) in Q4 2018, closing a stake of 500 shares — an estimated $8K sold.

Girard Partners first reported a position in PTEN in Q3 2018 and held it in 1 quarter. The position peaked at $8K in Q3 2018. 317 funds tracked by Wall St. Rank hold PTEN as of Q4 2018.

Girard Partners reported no remaining Patterson-UTI position as of Q4 2018 after selling out during the quarter.
Girard Partners sold 500 Patterson-UTI shares in Q4 2018, an estimated $8K.
Girard Partners first reported a position in Patterson-UTI in Q3 2018 and held it in 1 quarter.
Girard Partners's Patterson-UTI position peaked at $8K in Q3 2018.
317 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.